The Biostatistics Core Facility (BCF) of the University of Chicago Cancer Research Center (UCCRC) provides collaborative statistical support to UCCRC investigators engaged in clinical, basic, and population science research. The Facility is currently staffed by five PhD and two masters-level biostatisticians, in addition to the Scientific and Technical Directors. The services provided by the BCF include collaboration in the formation of study designs and data analysis plans, protocol development and statistical analysis for Phase I, Phase II, and Phase III clinical trials, assistance in the design and analysis of retrospective and prospective observational studies, and statistical collaboration on basic science and animal research projects. Clarification of specific aims and hypotheses to be tested, specification of primary and secondary outcome variables, sample-size (power) calculations, and development of data analysis plans are major areas of activity during the study design phase, followed by statistical analysis and assistance in the preparation of manuscripts for publication after completion of data collection. During the past five years, members of the BCF have co-authored over 80 collaborative publications. The BCF also interacts closely with the Cancer Clinical Trials Office and the Biomedical Informatics Core (a developing UCCRC Core) of the Biological Sciences Division on database development and data management procedures to ensure a high level of data quality for clinical trials and other studies conducted within the UCCRC. The BCF collaborates heavily with UCCRC investigators in the development of new grant applications, ranging from R21 """"""""quick trials"""""""" to multi-project SPORE grant submissions. Presently, BCF staff are engaged in active support of over 20 NIH/NCI-funded studies, as well as an industry-sponsored, multicenter, Phase III clinical trial. BCF members also serve on two key UCCRC committees, namely, the Clinical Trials Review Committee and the Scientific and Accrual Monitoring Committee, thereby ensuring that all protocols and cancer-related research projects undergo rigorous biostatistical review and that patient accrual to ongoing studies is adequate. Finally, BCF members participate in teaching activities, and conduct statistical methodological research in support of projects conducted within the UCCRC. Thus, the BCF plays a major role in meeting the scientific needs and objectives of the University of Chicago Cancer Research Center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-34
Application #
7843295
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
34
Fiscal Year
2009
Total Cost
$336,143
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Trujillo, Jonathan A; Sweis, Randy F; Bao, Riyue et al. (2018) T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer Immunol Res 6:990-1000
Zeng, Zongyue; Huang, Bo; Huang, Shifeng et al. (2018) The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs. Genes Dis 5:62-74
Lee, Ji-Hye; Park, Beom Seok; Han, Kang R et al. (2018) Insight Into the Interaction Between RNA Polymerase and VPg for Murine Norovirus Replication. Front Microbiol 9:1466
Cheng, Jason X; Chen, Li; Li, Yuan et al. (2018) RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun 9:1163
Johnson, Marianna B; Hoffmann, Joscelyn N; You, Hannah M et al. (2018) Psychosocial Stress Exposure Disrupts Mammary Gland Development. J Mammary Gland Biol Neoplasia 23:59-73
Sweis, Randy F; Zha, Yuanyuan; Pass, Lomax et al. (2018) Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer. J Immunother Cancer 6:24
Kathayat, Rahul S; Cao, Yang; Elvira, Pablo D et al. (2018) Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes. Nat Commun 9:334
Liu, Jun; Eckert, Mark A; Harada, Bryan T et al. (2018) m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol 20:1074-1083
Bhanvadia, Raj R; VanOpstall, Calvin; Brechka, Hannah et al. (2018) MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res 24:3668-3680
Wood, Kevin; Byron, Elizabeth; Janisch, Linda et al. (2018) Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol 41:963-966

Showing the most recent 10 out of 668 publications